News from cynosure, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 03, 2014, 08:37 ET

Cynosure Discusses Favorable Clinical Data from Trial of MonaLisa Touch™ Laser Treatment

 Cynosure, Inc. (NASDAQ: CYNO) today announced that clinical data will be presented at a national meeting of gynecologists and ObGyns that will...

Dec 03, 2014, 08:30 ET

Cynosure Discusses Favorable Clinical Data from Trial of MonaLisa Touch™ Laser Treatment

 Cynosure, Inc. (NASDAQ: CYNO) today announced that clinical data will be presented at a national meeting of gynecologists and ObGyns that will...

Nov 18, 2014, 08:00 ET

Cynosure Signs Exclusive Agreement to Market MonaLisa Touch™ in North America for Gynecology Indications

Cynosure, Inc. (NASDAQ: CYNO), today announced that it has signed an exclusive agreement with El.En. S.p.A. to market and distribute in North...

Oct 28, 2014, 08:00 ET

Cynosure Reports Record Third-Quarter Revenue of $71.5 Million, Up 18% Year-Over-Year

Cynosure, Inc. (Nasdaq: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications...

Oct 15, 2014, 08:30 ET

Cynosure To Host Third-Quarter 2014 Financial Results Conference Call On October 28

 Cynosure, Inc. (Nasdaq: CYNO), which develops and markets laser- and light-based aesthetic treatment systems for high-volume applications,...

Oct 06, 2014, 09:00 ET
Cynosure, Inc. Logo (PRNewsFoto/Cynosure, Inc.)

PicoSure® Is FDA-Cleared For Treatment Of Fine Lines And Wrinkles

Many people think fine lines and wrinkles appear as a result of aging, but hereditary factors and lifestyle choices such as smoking, sun exposure,...

Sep 24, 2014, 08:30 ET

Cynosure Receives Expanded FDA Clearance to Market PicoSure® for Treatment of Wrinkles

 Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications,...

Sep 10, 2014, 08:00 ET

Cynosure Promotes Chris Aronson to Vice President of North American Sales

Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today...

Sep 08, 2014, 07:30 ET

Cynosure Acquires Assets of RF Medical Device Manufacturer Ellman International, Inc.

Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today...

Aug 06, 2014, 08:30 ET

Cynosure to Present at Canaccord Genuity 34th Annual Growth Conference

 Cynosure, Inc. (NASDAQ: CYNO) today announced that its senior management will present at the Canaccord Genuity 34th Annual Growth Conference...

Jul 30, 2014, 08:30 ET
Tim Baker, Executive Vice President, Chief Operating Officer and Chief Financial Officer at Cynosure, Inc., will become President of the Company effective August 1, 2014.  He will continue to serve as CFO. (PRNewsFoto/Cynosure, Inc.)

Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President

Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today...

Jul 29, 2014, 14:20 ET
Cynosure, Inc. Logo (PRNewsFoto/Cynosure, Inc.)

Cynosure® Announces PicoSure® Is FDA-Cleared To Treat Acne Scars

 With acne as the most common skin condition affecting more than 60 million Americans today, it is no surprise that 20 million people have...

Jul 29, 2014, 08:00 ET

Cynosure Reports Second-Quarter 2014 Financial Results

Cynosure, Inc. (Nasdaq: CYNO), which develops and markets laser- and light-based aesthetic treatment systems for high-volume applications, today...

Jul 24, 2014, 08:30 ET

Cynosure Receives Expanded FDA Clearance to Market PicoSure™ for Treatment of Acne Scars

 Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications,...

Jul 16, 2014, 08:30 ET

Cynosure To Host Second-Quarter 2014 Financial Results Conference Call On July 29

 Cynosure, Inc. (Nasdaq: CYNO), which develops and markets laser- and light-based aesthetic treatment systems for high-volume applications,...

May 06, 2014, 08:00 ET

Cynosure Reports First-Quarter 2014 Financial Results

Cynosure, Inc. (Nasdaq: CYNO), which develops and markets laser- and light-based aesthetic treatment systems for high-volume applications, today...

Apr 22, 2014, 08:30 ET

Cynosure to Host First-Quarter 2014 Financial Results Conference Call on May 6

 Cynosure, Inc. (Nasdaq: CYNO), which develops and markets laser- and light-based aesthetic treatment systems for high-volume applications,...

Apr 02, 2014, 08:30 ET

Cynosure Announces 35 Clinical Research Presentations at 34th ASLMS Annual Conference

 Cynosure, Inc. (NASDAQ: CYNO) today announced that 21 oral abstracts and 14 e-posters are scheduled for presentation this week at LASER 2014,...

Feb 12, 2014, 08:00 ET

Cynosure Reports Record Fourth Quarter Revenue of $74.5 million, up 75% Year-over-Year

 Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications,...

Feb 06, 2014, 08:30 ET

Cynosure to Participate in Leerink Swann Global Healthcare Conference 2014

Cynosure, Inc. (NASDAQ: CYNO) today announced that President and Chief Executive Officer Michael Davin and Tim Baker, the Company's Executive Vice...